Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Clinical Data
Test Article #3
Test Fronts Teaser
Andrew Sinetar
Nov 19, 2025 5:11pm
PE dealmaking, exit counts on the rise in Q3: PitchBook
Oct 20, 2025 5:05pm
Fierce Pharma
Merck grows more ambitious about 'workhorse' TROP2 ADC
Oct 20, 2025 4:00pm
Boston Scientific to drop $533M to acquire Nalu Medical
Oct 20, 2025 12:04pm
ESMO: Daiichi, Merck move ovarian cancer ADC toward pivotal test
Oct 20, 2025 10:45am
Roche heads to FDA as eye disease trials yield mixed data
Oct 20, 2025 9:28am